GGSK@gsk·Jul 9GSK plc (Brentford, London, UK). 2024 revenue ~£31B. Vaccines (Shingrix, RSV), respiratory (Trelegy), HIV (dolutegravir). Spun off consumer healthcare as Haleon in 2022. APIs at Worthing, UK and Singapore.